HomeVSTM • NASDAQ
add
Verastem Inc
Previous close
$9.31
Day range
$9.02 - $9.38
Year range
$4.26 - $15.19
Market cap
233.21M USD
Avg Volume
130.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 31.14M | 84.85% |
Net income | -27.37M | -62.83% |
Net profit margin | — | — |
Earnings per share | -1.10 | -14.58% |
EBITDA | -31.13M | -85.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 137.13M | 56.02% |
Total assets | 149.72M | 57.51% |
Total liabilities | 71.18M | 49.36% |
Total equity | 78.53M | — |
Shares outstanding | 25.30M | — |
Price to book | 4.10 | — |
Return on assets | -47.78% | — |
Return on capital | -56.02% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -27.37M | -62.83% |
Cash from operations | -29.68M | -78.63% |
Cash from investing | 12.44M | -4.52% |
Cash from financing | -446.00K | — |
Net change in cash | -17.69M | -392.65% |
Free cash flow | -13.32M | -28.35% |
About
Verastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Website
Employees
73